In vivo treatment with a monoclonal chimeric anti-CD4 antibody results in prolonged depletion of circulating CD4(+) cells in chimpanzees

Chimeric M-T412 (cM-T412), an anti-CD4 antibody, was tolerated in chimpanzees at a dosage of 5 mg/kg per day for up to 7 consecutive days, or 5 mg/kg per dose, twice weekly for 4 weeks. All cM-T412-treated chimpanzees showed a prolonged CD4 cell depression. Weak chimpanzee antibody responses to chim...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Jonker, M., Slingerland, W., Treacy, G., van Eerd, P., Pak, K. Y., Wilson, E., Tam, S., Bakker, K., Lobuglio, A. F., Rieber, P., Riethmuller, G., Daddona, P. E., Iuliucci, J.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 1993
Gaiak:
Experimental Immunotherapy
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC1554916/
https://ncbi.nlm.nih.gov/pubmed/8103714
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak